PARP1 and breast carcinoma: Notably, a recent study reported that in BRCA-mutant breast cancers, PARP1 amplifications occur significantly more frequently in post-treatment recurrent lesions than in primary tumors [8], suggesting that PARP1 amplifications may contribute to post-treatment recurrence in BRCA-mutant breast cancer.